Insider Transactions in Q1 2023 at Biocryst Pharmaceuticals Inc (BCRX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 21
2023
|
Jon P Stonehouse President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
31,055
+2.9%
|
$93,165
$3.22 P/Share
|
|
Feb 28
2023
|
Robert Alexander Ingram Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,259
+2.2%
|
$18,072
$8.85 P/Share
|
|
Feb 28
2023
|
Vincent Milano Director |
BUY
Grant, award, or other acquisition
|
Direct |
635
+1.96%
|
$5,080
$8.85 P/Share
|
|
Feb 28
2023
|
Alan G Levin Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,271
+6.27%
|
$10,168
$8.85 P/Share
|
|
Feb 28
2023
|
Theresa Heggie Director |
BUY
Grant, award, or other acquisition
|
Direct |
635
+1.96%
|
$5,080
$8.85 P/Share
|
|
Feb 01
2023
|
Jon P Stonehouse President & CEO |
SELL
Open market or private sale
|
Direct |
100,000
-9.02%
|
$1,000,000
$10.38 P/Share
|
|
Feb 01
2023
|
Jon P Stonehouse President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+8.27%
|
$500,000
$5.45 P/Share
|
|
Jan 31
2023
|
Kenneth B Lee Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+22.35%
|
$15,000
$1.71 P/Share
|